ORIFARM GROUP A/S — Credit Rating and Financial Key Figures

ORIFARM GROUP A/S (CVR number: 27347282K) is a company from ODENSE. The company reported a net sales of 1816 mEUR in 2024, demonstrating a growth of 15.8 % compared to the previous year. The operating profit percentage was at 3.8 % (EBIT: 69.4 mEUR), while net earnings were 3260 kEUR. The profitability of the company measured by Return on Assets (ROA) was 5.8 %, which can be considered decent but Return on Equity (ROE) was 1.1 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at 31.3 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. ORIFARM GROUP A/S's liquidity measured by quick ratio was 0.6 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.